Jacob Witten

Jacob Witten

Auto-generated profile, based on publicly available information

Jacob Witten

Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2023 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
AJAllen Y. Jiang
Allen Y. Jiang
JWJacob Witten
Jacob Witten
IRIdris O. Raji
Idris O. Raji
FEFeyisayo Eweje
Feyisayo Eweje
CMCorina MacIsaac
Corina MacIsaac
DADaniel G. Anderson
Daniel G. Anderson

10 December 2024 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
JWJacob Witten
Jacob Witten
IRIdris Raji
Idris Raji
RMRajith S. Manan
Rajith S. Manan
EBEmily Beyer
Emily Beyer
SBSandra Bartlett
Sandra Bartlett
DADaniel G. Anderson
Daniel G. Anderson

16 May 2017 in Nanoscale
Verified
Journal Article
Open access
PDF file
JWJacob Witten
Jacob Witten
KRKatharina Ribbeck
Katharina Ribbeck
Biological hydrogels such as mucus, extracellular matrix, biofilms, and the nuclear pore have diverse functions and compositions, but all act as selectively permeable barriers to the diffusion of particles. Each barrier has a crosslinked polymeric mesh that blocks penetration of large particles such as pathogens, nanotherapeutics, or macromolecules. These polymeric meshes also employ interactive filtering, in which affinity between solutes and the gel matrix controls permeability. Interactive filtering affects the transport of particles of all sizes including peptides, antibiotics, and nanoparticles and in many cases this filtering can be described in terms of the effects of charge and hydrophobicity. The concepts described in this review can guide strategies to exploit or overcome gel barriers, particularly for applications in diagnostics, pharmacology, biomaterials, and drug delivery.

12 July 2019 in bioRxiv
Verified
Preprint
Open access
JWJacob Witten
Jacob Witten
ZWZack Witten
Zack Witten
Antimicrobial peptides (AMPs) are naturally occurring or synthetic peptides that show promise for treating antibiotic-resistant pathogens. Machine learning techniques are increasingly used to identify naturally occurring AMPs, but there is a dearth of purely computational methods to design novel effective AMPs, which would speed AMP development. We collected a large database, Giant Repository of AMP Activities (GRAMPA), containing AMP sequences and associated MICs. We designed a convolutional neural network to perform combined classification and regression on peptide sequences to quantitatively predict AMP activity against Escherichia coli . Our predictions outperformed the state of the art at AMP classification and were also effective at regression, for which there were no publicly available comparisons. We then used our model to design novel AMPs and experimentally demonstrated activity of these AMPs against the pathogens E. coli, Pseudomonas aeruginosa , and Staphylococcus aureus . Data, code, and neural network architecture and parameters are available at https://github.com/zswitten/Antimicrobial-Peptides .

22 February 2019 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
TSTahoura Samad
Tahoura Samad
JCJulia Y Co
Julia Y Co
JWJacob Witten
Jacob Witten
KRKatharina Ribbeck
Katharina Ribbeck

4 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KSK. B. Smith-Dupont
K. B. Smith-Dupont
CWC. E. Wagner
C. E. Wagner
JWJ. Witten
J. Witten
KCK. Conroy
K. Conroy
HRH. Rudoltz
H. Rudoltz
KRK. Ribbeck
K. Ribbeck
Preterm birth is the leading cause of neonatal mortality, and is frequently associated with intra-amniotic infection hypothesized to arise from bacterial ascension across a dysfunctional cervical mucus plug. To study this dysfunction, we assessed the permeability of cervical mucus from non-pregnant ovulating (n = 20) and high- (n = 9) and low-risk (n = 16) pregnant women to probes of varying sizes and surface chemistries. We found that the motion of negatively charged, carboxylated microspheres in mucus from pregnant patients was significantly restricted compared to ovulating patients, but not significantly different between high- and low-risk pregnant women. In contrast, charged peptide probes small enough to avoid steric interactions, but sensitive to the biochemical modifications of mucus components exhibited significantly different transport profiles through mucus from high- and low-risk patients. Thus, although both microstructural rearrangements of the components of mucus as well as biochemical modifications to their adhesiveness may alter the overall permeability of the cervical mucus plug, our findings suggest that the latter mechanism plays a dominant role in the impairment of the function of this barrier during preterm birth. We expect that these probes may be readily adapted to study the mechanisms underlying disease progression on all mucosal epithelia, including those in the mouth, lungs, and gut.